Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
16.2M
-
Shares change
-
+177K
-
Total reported value, excl. options
-
$11.9M
-
Value change
-
-$5.71K
-
Put/Call ratio
-
0.36
-
Number of buys
-
17
-
Number of sells
-
-20
-
Price
-
$0.74
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q3 2023
61 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q3 2023.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2M shares
of 129M outstanding shares and own 12.5% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.68M shares), BlackRock Inc. (2.89M shares), Laurion Capital Management LP (2.23M shares), RENAISSANCE TECHNOLOGIES LLC (1.24M shares), GEODE CAPITAL MANAGEMENT, LLC (1.1M shares), STATE STREET CORP (436K shares), GSA CAPITAL PARTNERS LLP (347K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (249K shares), MILLENNIUM MANAGEMENT LLC (240K shares), and NORTHERN TRUST CORP (215K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.